What types of peritoneal dialysis (PD) bags are prescribed for a patient with hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peritoneal Dialysis Prescription for Hypertensive Patients

For patients with hypertension, the optimal peritoneal dialysis (PD) prescription should include icodextrin for long dwells, shorter dwell times with glucose-based solutions for high transporters, and minimization of hypertonic glucose solutions to achieve euvolemia while controlling blood pressure. 1, 2

Volume Management Strategies in PD for Hypertension

Volume overload is the primary contributor to hypertension in PD patients. The following strategies should be implemented:

  • Maximize peritoneal ultrafiltration by optimizing the PD prescription to achieve euvolemia 1, 2
  • Use icodextrin solution for long dwells (nocturnal dwell in CAPD patients and day dwell in APD patients) to increase ultrafiltration and decrease extracellular fluid volume 1
  • Consider shortening dwell times with glucose-based solutions, especially for high transporters, to prevent fluid reabsorption 1
  • Avoid long-duration dwells that are associated with ineffective fluid removal or net fluid resorption 1
  • In APD patients, consider either shortening the day dwell or draining out the day dwell and replacing it with fresh dialysis solution partway through the day 1
  • In CAPD patients, consider switching to APD without a long day dwell or using a night-exchange device to divide the nocturnal dwell into 2 shorter dwells 1

Specific PD Solution Recommendations

Icodextrin Solutions

  • Use icodextrin for the long dwell (day dwell in APD, overnight dwell in CAPD) 1, 2
  • Randomized controlled trials have shown icodextrin both increases peritoneal ultrafiltration and decreases extracellular fluid volume 1
  • With icodextrin in place, there is no need to drain a day dwell early to optimize ultrafiltration 1
  • Monitor for potential increased peritoneal permeability with long-term use of icodextrin 3

Glucose-Based Solutions

  • Minimize use of hypertonic glucose solutions due to concerns about peritoneal membrane damage and adverse metabolic effects 1
  • When necessary, use more hypertonic glucose solutions strategically for shorter dwells rather than long dwells 1
  • Consider biocompatible, neutral pH, or low glucose degradation product solutions which may help preserve residual kidney function and maintain peritoneal membrane function 1

Modality Considerations (APD vs CAPD)

  • APD may provide better blood pressure control compared to CAPD in some patients, with studies showing a 4 mmHg decrease in systolic blood pressure when transitioning from CAPD to APD 4
  • Pay close attention to sodium sieving effect in APD patients with multiple short overnight dwells, which may compromise BP control 1
  • Consider using fewer than four overnight exchanges during 8 hours in APD to minimize sodium sieving 1
  • No definitive evidence suggests one PD modality is superior to the other for volume control; selection should consider patient-specific factors 1

Additional Management Strategies

  • Preserve residual kidney function (RKF) as it is strongly associated with better BP control 5
  • For patients with RKF, consider high-dose loop diuretics to enhance urinary sodium and water removal 1
  • ACE inhibitors and ARBs may help maintain urinary volume and clearance in patients with RKF 1
  • Restrict dietary sodium intake if persistent hypertension and fluid overload are present 1
  • Monitor salt and water removal by measuring daily urinary volume/sodium content and the difference between dialysate effluent and infused dialysis solution 1
  • Consider experimental approaches such as low-sodium dialysate, though these require further evaluation and may increase risk of hypotensive episodes 1, 6

Monitoring and Assessment

  • Assess blood pressure and volume status monthly 1
  • Evaluate drain volume, residual kidney function, and dietary salt/water intake monthly 1
  • More frequent clinical examination may be needed in the initial weeks of PD therapy when target weight is being established 1
  • Pay particular attention to net peritoneal fluid absorption during long duration dwells 1

By implementing these strategies, hypertension can be effectively managed in PD patients while minimizing complications and preserving peritoneal membrane function and residual kidney function.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hypertension During Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2006

Research

Transition between peritoneal dialysis modalities: Impact on blood pressure levels and drug prescription in a national multicentric cohort.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2025

Research

Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001

Research

Single-dwell treatment with a low-sodium solution in hypertensive peritoneal dialysis patients.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.